Search

Search Constraints

You searched for: Author/Creator Favier, Laure

Search Results

1. 2022-RA-1551-ESGO Impact of age on first line treatments of ovarian cancer and their outcomes: results from the Unicancer ESME OVR real-world database. (20th October 2022)

2. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial. Issue 2 (February 2021)

3. Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers?. (November 2021)

4. Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial. (March 2023)

5. Impact on Health‐Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial. (25th March 2020)

6. MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer. Issue 3 (11th March 2022)

7. Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study. Issue 1 (1st January 2020)

8. Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study. Issue 1 (20th May 2020)

9. Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study. Issue 1 (20th May 2020)

10. Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer. (2nd September 2017)